Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HHS Office of Inspector General (OIG)
Payers
OIG: Jury still out on vertical consolidation's impact in Part D
An analysis from the Office of Inspector General found similar net cost for drugs through vertically-integrated Part D plans compared to other plans.
Paige Minemyer
May 19, 2026 11:58am
Behavioral health networks often limited in MA, Medicaid: OIG
Oct 9, 2025 5:55am
HHS looks to crack down on healthcare information blocking
Sep 3, 2025 5:00pm
More patients leaving hospital against medical advice: HHS OIG
Aug 22, 2025 6:45am
Over half of patient harm events missed by hospitals: HHS OIG
Jul 30, 2025 5:50am
DOJ announces largest-ever $14.6B healthcare fraud takedown
Jun 30, 2025 4:40pm
